Routine use of ramipril is cost-effective after percutaneous coronary intervention

被引:0
|
作者
Canto, JG
Hillegass, WB
Fincher, C
Mallick, R
机构
[1] Univ Alabama, Birmingham, AL USA
[2] Wyeth Ayerst Res, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:524A / 524A
页数:1
相关论文
共 50 条
  • [1] IS INTERVENTION COST-EFFECTIVE
    RECKLESS, JPD
    POSTGRADUATE MEDICAL JOURNAL, 1992, 68 (805) : 882 - 883
  • [2] Use of routine healthcare data in safe and cost-effective drug use
    Currie, CJ
    MacDonald, TM
    DRUG SAFETY, 2000, 22 (02) : 97 - 102
  • [3] Use of Routine Healthcare Data in Safe and Cost-Effective Drug Use
    Craig J. Currie
    Tom M. MacDonald
    Drug Safety, 2000, 22 : 97 - 102
  • [4] Digital zoom is a useful, simple, and cost-effective method of reducing radiation exposure in percutaneous coronary intervention
    Kenji Hasegawa
    Norio Umemoto
    Sho Inoue
    Yuri Iio
    Naoki Shibata
    Takashi Mizutani
    Akinori Sawamura
    Tsuyoshi Sugiura
    Toshio Taniguchi
    Toru Asai
    Michiharu Yamada
    Hideki Ishii
    Toyoaki Murohara
    Kiyokazu Shimizu
    Cardiovascular Intervention and Therapeutics, 2020, 35 : 353 - 360
  • [5] Selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention: A cost-effective protocol.
    Kini, A
    Mitre, C
    Tan, R
    Suleman, J
    Koelemij, H
    Blum, L
    Reich, D
    Sharma, SK
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 86 (8A): : 71I - 71I
  • [6] Digital zoom is a useful, simple, and cost-effective method of reducing radiation exposure in percutaneous coronary intervention
    Hasegawa, Kenji
    Umemoto, Norio
    Inoue, Sho
    Iio, Yuri
    Shibata, Naoki
    Mizutani, Takashi
    Sawamura, Akinori
    Sugiura, Tsuyoshi
    Taniguchi, Toshio
    Asai, Toru
    Yamada, Michiharu
    Ishii, Hideki
    Murohara, Toyoaki
    Shimizu, Kiyokazu
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2020, 35 (04) : 353 - 360
  • [7] Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?
    Bijan J. Borah
    Naveen Pereira
    Michael E. Farkouh
    Cardiovascular Drugs and Therapy, 2017, 31 : 1 - 3
  • [8] Personalizing Antiplatelet Therapies for Acute Coronary Syndrome (ACS) in Patients Undergoing Percutaneous Coronary Intervention (PCI): Are They Cost-effective?
    Borah, Bijan J.
    Pereira, Naveen
    Farkouh, Michael E.
    CARDIOVASCULAR DRUGS AND THERAPY, 2017, 31 (01) : 1 - 3
  • [9] Evaluation of routine functional testing after percutaneous coronary intervention
    Eisenberg, MJ
    Blankenship, JC
    Huynh, T
    Azrin, M
    Pathan, A
    Sedlis, S
    Panja, M
    Starling, MR
    Beyar, R
    Azoulay, A
    Caron, J
    Pilote, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (06): : 744 - 747
  • [10] Use of some cost-effective technologies for a routine clinical pathology laboratory
    Vazquez, Mercedes
    Anfossi, Laura
    Ben-Yoav, Hadar
    Dieguez, Lorena
    Karopka, Thomas
    Della Ventura, Bartolomeo
    Abalde-Cela, Sara
    Minopoli, Antonio
    Di Nardo, Fabio
    Shukla, Vikas Kumar
    Teixeira, Alexandra
    Tvarijonaviciute, Asta
    Franco-Martinez, Lorena
    LAB ON A CHIP, 2021, 21 (22) : 4330 - 4351